Stockreport

Barclays Raises Syndax (SNDX) PT to $35 on Positive Management Update, Model Rerating [Yahoo! Finance]

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com
PDF Syndax Pharmaceuticals Inc. (NASDAQ: SNDX ) is one of the most promising stocks with huge upside potential . On November 24, Barclays raised the firm's price target on S [Read more]